FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
from PR Newswire
BioLineRx to Present at the Annual Roth Conference in California
Today 10:52 EST
VBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors
January 20, 2015
BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares
Today 9:03 EST
BioLineRx Announces Regulatory Submission for Phase 2b Trial for Novel AML Consolidation Treatment
March 02, 2015
BioLineRx to Present at 2015 BIO CEO & Investor Conference in New York on February 10
February 03, 2015
BioLineRx Announces Completion of Enrollment in CE Mark Registration Trial of BCM (BL-1040), a Novel Medical Device for Prevention of Cardiac Remodeling Following Acute Myocardial Infarction
January 14, 2015
BioLineRx Completes Dose Escalation Stage of Phase 1 Trial for Novel Stem Cell Mobilization Treatment
January 06, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here